<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05622968</url>
  </required_header>
  <id_info>
    <org_study_id>NMRR ID-22-00349-EQQ</org_study_id>
    <nct_id>NCT05622968</nct_id>
  </id_info>
  <brief_title>Outpatient Induction of Labour Using Intracervical Foley Catheter</brief_title>
  <acronym>OFC</acronym>
  <official_title>Outpatient Cervical Ripening With Foley Catheter for Induction of Labour in Low Risk Women: a Quasi-experimental Study (OFC Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Kemaman</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Kemaman</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective quasi-experimental study between a study population who will receive outpatient&#xD;
      induction of labour using intracervical Foley catheter, followed by the inpatient induction&#xD;
      using intravaginal prostaglandin and a control group of women with similar characteristics&#xD;
      undergoing inpatient labour induction with intravaginal prostaglandin (standard management)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be conducted among pregnant women in 2 to 5th pregnancy who have no&#xD;
      significant risk factors and planned for induction of labour. The eliiable women will be&#xD;
      recruited from 4 health clinics within the district (of Kemaman, Malaysia) and located within&#xD;
      20 km from the hospital.&#xD;
&#xD;
      Willing participants will be seen in the hospital at the planned induction date and&#xD;
      reassessed. Should they be suitable for induction of labour using Foley catheter on&#xD;
      outpatient basis, a 18G Foley catheter will be inserted into the cervical canal and the&#xD;
      balloon inflated with sterile water (60 mls). The fetal well being will be assessed and the&#xD;
      women allowed to go home with instruction related to the induction and the study.&#xD;
&#xD;
      Those who do not enter the active phase of labour will be admitted to the ward 24 hours later&#xD;
      and will undergo inpatient induction of labour using intravaginal prostaglandin&#xD;
      (Dinoprostone) according to the local protocol.&#xD;
&#xD;
      These women will be compared with a control group comprising of women with similar&#xD;
      characteristics and undergo inpatient induction of labour with intravaginal Dinoprostone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2023</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Induction of labour-delivery interval</measure>
    <time_frame>Induction of labour (intravaginal prostaglandin) to delivery</time_frame>
    <description>The mean interval between the start of inpatient cervical ripening and delivery (from the start of cervical ripening with Dinoprostone to the delivery of the baby)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success rate of induction of labour within 12 hours</measure>
    <time_frame>From the start of inpatient cervical ripening and delivery</time_frame>
    <description>The percentage of vaginal delivery within 12 hours of inpatient cervical ripening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success rate of induction of labour within 24 hours</measure>
    <time_frame>From the start of inpatient cervical ripening and delivery</time_frame>
    <description>The percentage of vaginal delivery within 24 hours of inpatient cervical ripening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delivery outcome</measure>
    <time_frame>Induction to delivery</time_frame>
    <description>Percentage of caesarean section and instrumental delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse event</measure>
    <time_frame>Induction to delivery</time_frame>
    <description>Incidence of uterine tachysystole and hyperstimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Labour augmentation</measure>
    <time_frame>Induction to delivery</time_frame>
    <description>Duration and maximum oxytocin dose used for labour augmentation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum pain recorded</measure>
    <time_frame>Induction to delivery</time_frame>
    <description>Maximum recorded contraction pain during cervical ripening (using Visual Analogue Scale of 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of chorioamnionitis</measure>
    <time_frame>Induction to 24 hours after delivery</time_frame>
    <description>maternal temperature is greater than or equal to 39.0°C or when the maternal temperature is 38.0-38.9°C and one additional clinical risk factor is present</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesia requirement</measure>
    <time_frame>Induction to delivery</time_frame>
    <description>Prevalence of analgesia required during induction of labour</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postpartum hemorrhage</measure>
    <time_frame>Delivery to 24 hours after delivery</time_frame>
    <description>Primary postpartum haemorrhage (blood loss of more than 500mls within 24 hours of delivery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Apgar score</measure>
    <time_frame>Delivery to 10 minutes after birth</time_frame>
    <description>Incidence of low Apgar score (less than 7) at 5 minutes after delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal intubation</measure>
    <time_frame>Delivery to 30 minutes after birth</time_frame>
    <description>Incidence of neonates requiring intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal seizure</measure>
    <time_frame>Delivery to 24 hours after birth</time_frame>
    <description>Incidence of neonate with seizure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal complication</measure>
    <time_frame>Delivery to 24 hours after birth</time_frame>
    <description>Admission to the Neonatal Intensive Care Unit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Pregnancy Related</condition>
  <condition>Induction of Labor Affected Fetus / Newborn</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women who are planned for elective delivery for obstetric indication(s) and undergo outpatient induction of labour using Foley catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Women who are planned for elective delivery for obstetric indication(s) and undergo inpatient induction of labour using intravaginal prostaglandin</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Foley catheter</intervention_name>
    <description>Insertion of 18G Foley catheter into the cervical canal and inflating the balloon to 60 mls using sterile water</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>urinary catheter</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravaginal prostaglandin E2</intervention_name>
    <description>Insertion of intravaginal Dinoprostone</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Dinoprostone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 year old&#xD;
&#xD;
          -  Singleton pregnancy&#xD;
&#xD;
          -  Cephalic presentation&#xD;
&#xD;
          -  Multiparous women in their 2nd to 5th pregnancy (Para 1 to 4)&#xD;
&#xD;
          -  Gestational age between 37+0 and 41+0 weeks.&#xD;
&#xD;
          -  No previous uterine surgery (lower segment caesarean section, upper segment caesarean&#xD;
             section, myomectomy&#xD;
&#xD;
          -  Resides within 30 minutes drive from Hospital Kemaman&#xD;
&#xD;
          -  Has access to a telephone&#xD;
&#xD;
          -  Has reliable transportation (i.e. able to get to the hospital immediately without the&#xD;
             need of ambulance)&#xD;
&#xD;
          -  Acceptance of participation by the signing of a written consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy with non-cephalic presentation&#xD;
&#xD;
          -  Prior cesarean delivery&#xD;
&#xD;
          -  Gestational hypertension or preeclampsia on 2 or more medications&#xD;
&#xD;
          -  Diabetes in pregnancy on high dose medication(s); insulin of more than 60 units per&#xD;
             day or combination of insulin and oral hypoglycemic agent&#xD;
&#xD;
          -  Low lying placenta or placenta praevia&#xD;
&#xD;
          -  Rupture of amniotic membrane&#xD;
&#xD;
          -  Primiparae and grandmultiparae (para 5 or more)&#xD;
&#xD;
          -  Multiple pregnancy&#xD;
&#xD;
          -  Fetal death&#xD;
&#xD;
          -  Fetal anomalies: defined as the presence of a major fetal anomaly of any organ system&#xD;
&#xD;
          -  Fetal growth restriction: defined as an ultrasound derived estimated fetal weight less&#xD;
             than the 10th percentile for gestational age&#xD;
&#xD;
          -  Suspected macrosomia: defined as an ultrasound derived estimated fetal weight of more&#xD;
             than 90th centile for gestational age&#xD;
&#xD;
          -  Oligohydramnios: ultrasound measured amniotic fluid index (AFI) less than the 10th&#xD;
             percentile for gestational age&#xD;
&#xD;
          -  Polyhydramnios: defined as an AFI of 24 cm or greater or a single deepest vertical&#xD;
             pocket of 8 cm or greater&#xD;
&#xD;
          -  Latex allergy&#xD;
&#xD;
          -  Contraindication to induction of labor&#xD;
&#xD;
          -  Evidence of active phase of labor&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>All low risk pregnant women with obstetric indication for induction of labour at term</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zahar Zakaria, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Kemaman</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zahar Zakaria, MD</last_name>
    <phone>6098513333</phone>
    <phone_ext>3548</phone_ext>
    <email>zazuarz@yahoo.co.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mazrin Nur Mohd Ali, MD</last_name>
    <phone>6098513333</phone>
    <email>mazrin_0202@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Kemaman</name>
      <address>
        <city>Kampong Kemaman</city>
        <state>Terengganu</state>
        <zip>24000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <reference>
    <citation>Sharp AN, Stock SJ, Alfirevic Z. Outpatient induction of labour in the UK: a survey of practice. Eur J Obstet Gynecol Reprod Biol. 2016 Sep;204:21-3. doi: 10.1016/j.ejogrb.2016.06.023. Epub 2016 Jul 30.</citation>
    <PMID>27513897</PMID>
  </reference>
  <results_reference>
    <citation>Royal College of Obstetricians and Gynaecologists. Evidence-based Clinical Guideline No. 9. Induction of labour</citation>
  </results_reference>
  <results_reference>
    <citation>ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009 Aug;114(2 Pt 1):386-397. doi: 10.1097/AOG.0b013e3181b48ef5. No abstract available.</citation>
    <PMID>19623003</PMID>
  </results_reference>
  <results_reference>
    <citation>Leduc D, Biringer A, Lee L, Dy J; CLINICAL PRACTICE OBSTETRICS COMMITTEE; SPECIAL CONTRIBUTORS. Induction of labour. J Obstet Gynaecol Can. 2013 Sep;35(9):840-857. doi: 10.1016/S1701-2163(15)30842-2. English, French.</citation>
    <PMID>24099451</PMID>
  </results_reference>
  <results_reference>
    <citation>Dowswell T, Kelly AJ, Livio S, Norman JE, Alfirevic Z. Different methods for the induction of labour in outpatient settings. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007701. doi: 10.1002/14651858.CD007701.pub2.</citation>
    <PMID>20687092</PMID>
  </results_reference>
  <results_reference>
    <citation>Vogel JP, Osoti AO, Kelly AJ, Livio S, Norman JE, Alfirevic Z. Pharmacological and mechanical interventions for labour induction in outpatient settings. Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD007701. doi: 10.1002/14651858.CD007701.pub3.</citation>
    <PMID>28901007</PMID>
  </results_reference>
  <results_reference>
    <citation>Dong S, Khan M, Hashimi F, Chamy C, D'Souza R. Inpatient versus outpatient induction of labour: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2020 Jun 30;20(1):382. doi: 10.1186/s12884-020-03060-1. Erratum In: BMC Pregnancy Childbirth. 2020 Jul 13;20(1):403.</citation>
    <PMID>32605542</PMID>
  </results_reference>
  <results_reference>
    <citation>Croll DMR, Hoge PC, Verhoeven CJM, de Boer MA, Bloemenkamp KWM, de Heus R. Changes in local protocols on inpatient cervical priming and introduction of outpatient priming: A nationwide survey in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2021 Aug;263:148-152. doi: 10.1016/j.ejogrb.2021.06.004. Epub 2021 Jun 10.</citation>
    <PMID>34214801</PMID>
  </results_reference>
  <results_reference>
    <citation>Amorosa JM, Stone JL. Outpatient cervical ripening. Semin Perinatol. 2015 Oct;39(6):488-94. doi: 10.1053/j.semperi.2015.07.014. Epub 2015 Sep 11.</citation>
    <PMID>26365009</PMID>
  </results_reference>
  <results_reference>
    <citation>Kruit H, Heikinheimo O, Ulander VM, Aitokallio-Tallberg A, Nupponen I, Paavonen J, Rahkonen L. Foley catheter induction of labor as an outpatient procedure. J Perinatol. 2016 Aug;36(8):618-22. doi: 10.1038/jp.2016.62. Epub 2016 Apr 14.</citation>
    <PMID>27078202</PMID>
  </results_reference>
  <results_reference>
    <citation>Sciscione AC, Muench M, Pollock M, Jenkins TM, Tildon-Burton J, Colmorgen GH. Transcervical Foley catheter for preinduction cervical ripening in an outpatient versus inpatient setting. Obstet Gynecol. 2001 Nov;98(5 Pt 1):751-6. doi: 10.1016/s0029-7844(01)01579-4.</citation>
    <PMID>11704164</PMID>
  </results_reference>
  <results_reference>
    <citation>Diederen M, Gommers J, Wilkinson C, Turnbull D, Mol B. Safety of the balloon catheter for cervical ripening in outpatient care: complications during the period from insertion to expulsion of a balloon catheter in the process of labour induction: a systematic review. BJOG. 2018 Aug;125(9):1086-1095. doi: 10.1111/1471-0528.15047. Epub 2018 Jan 10.</citation>
    <PMID>29211328</PMID>
  </results_reference>
  <results_reference>
    <citation>Stephenson E, Borakati A, Simpson I, Eedarapalli P. Foley catheter for induction of labour: a UK observational study. J Obstet Gynaecol. 2020 Nov;40(8):1064-1068. doi: 10.1080/01443615.2019.1676213. Epub 2019 Dec 3.</citation>
    <PMID>31793372</PMID>
  </results_reference>
  <results_reference>
    <citation>Turnbull D, Adelson P, Oster C, Bryce R, Fereday J, Wilkinson C. Psychosocial outcomes of a randomized controlled trial of outpatient cervical priming for induction of labor. Birth. 2013 Jun;40(2):75-80. doi: 10.1111/birt.12035. Epub 2013 Mar 25.</citation>
    <PMID>24635460</PMID>
  </results_reference>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 14, 2022</study_first_submitted>
  <study_first_submitted_qc>November 14, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2022</study_first_posted>
  <last_update_submitted>November 21, 2022</last_update_submitted>
  <last_update_submitted_qc>November 21, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Kemaman</investigator_affiliation>
    <investigator_full_name>Zahar Azuar Zakaria</investigator_full_name>
    <investigator_title>Principal Investigator, Head of Obstetric &amp; Gynecology Department, Senior Consultant</investigator_title>
  </responsible_party>
  <keyword>outpatient induction</keyword>
  <keyword>Foley catheter</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dinoprostone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to share for now</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

